The semi-annual report disclosure season has arrived, what is the performance of the major listed medical device companies in China?
The semi-annual report is the financial statement of the listed company in the first half of each fiscal year, including the financial statements describing the company's operating status, as well as the balance sheet, cash flow statement, profit and loss statement, etc.
Recently, some medical device listed companies have taken the lead in disclosing their semi-annual reports, or semi-annual report performance forecasts. Let's see what happens separately?
Yuyue Medical [Jiangsu Yuyue Medical Equipment Co., Ltd.]
Revenue: The performance maintained rapid growth, e-commerce and equipment
In the first half of 2016, the total revenue of Yuyue Medical Business reached 1.428 billion yuan, up 30.84% ​​year-on-year; the net profit attributable to shareholders of listed companies was 331 million yuan, up 31.55% year-on-year; net attributable to shareholders of listed companies after deducting non-recurring gains and losses The profit was 308 million yuan, a year-on-year increase of 35.7%.
The gross profit of the company's sales was 41.06%, which was basically the same as the same period of last year.
During the reporting period, the company's performance maintained a relatively fast growth rate, mainly due to the rapid growth of the e-commerce platform and the combination of the Shanghai Machinery Group.
Assets: During the reporting period, the company's total assets amounted to 5.687 billion yuan, and the asset-liability ratio was 16.29%. The net cash flow from operating activities was 285 million yuan, up 45.48% year-on-year; the balance of cash and cash equivalents was 2.86 billion yuan. The company's assets, operations and financial status have improved significantly.
Major events in the company's reporting period:
1. Completion of non-public offering of shares, the net proceeds raised of 2.527 billion yuan have been fully in place, providing strong capital support for the company's rapid development in the next few years.
2. To complete the employee stock ownership plan, 107 senior executives and core management and technical personnel jointly invested 240 million yuan to become shareholders of the company, greatly enhancing cohesion and competitiveness.
3. The establishment of a Tibetan subsidiary provides a new way for the company's core product oxygen generators to grow.
4. Investing in YUWELL Germany GmBH, a subsidiary in Tuttlingen, Germany, to open an international journey.
Shang Rong Medical [Shenzhen Shangrong Medical Co., Ltd.]
Revenue: The performance is declining, but it is expected to grow substantially throughout the year.
In the first half of 2016, the company achieved operating income of 850 million, down 1.93% year-on-year; net profit of returning to mother was 83.22 million yuan, up 20.89%; deducting non-net profit was 83.86 million, up 21.90%. Among them, the medical professional project income was 292 million, an increase of 44.28%, and the growth rate accelerated; the construction project income was 67.39 million, an increase of 75.23%.
The company's revenue declined in the first half of the year, mainly due to the fact that some of the projects under construction have not yet been settled, and the internal transactions in the Pulder consolidated income last year did not offset the impact. In the first half of 2016, the company's main business grew steadily, excluding the impact of the merger revenue.
From the perspective of the specific project progress, many hospitals invested and constructed by the company have been completed and are being audited and settled, or will be completed soon. It is expected that in the second half of the year, the company will usher in an order-intensive settlement period, and the hospital construction revenue will achieve substantial growth throughout the year, and will drive the growth of the company's consumables sales revenue.
Financial status: During the reporting period, the company's gross profit margin was 29.52%, an increase of 7.04 percentage points year-on-year. The expense ratio was 12.72%, an increase of 1.53 percentage points, of which sales expenses were 3.69%, up 0.48 percentage points, management expenses were 8.10%, up 0.41 percentage points, financial expenses 0.93% were increased by 0.64 percentage points, and operating cash flow per share was -0.08 yuan. , down by -21%.
Air Hose Reel,Mini Air Hose Reel,Air Compressor Hose Reel,Industrial Air Hose Reel
NINGBO QIKAI ENVIRONMENTAL TECHNOLOGY CO.,LTD , https://www.water-hose-reel.com